Arboviral disease is a general term used to describe infections caused by a group of viruses spread among humans by the bite of infected arthropods (insects) such as mosquitoes and ticks; for instance, California encephalitis, Chikungunya, dengue, Eastern equine encephalitis, Powassan, St. Louis encephalitis, West Nile, Yellow Fever, and Zika. Other diseases spread by the bite of infected arthropods that are not viral infections, such as Lyme disease, which is a bacterial infection, and babesiosis, which is a parasitic infection, are not arboviral. The onset of these infections is witnessed during warm weather months, when mosquitoes and ticks are active.. Young children and the elderly appear to be most susceptible to arboviral infection. People who travel to or reside in areas where certain arboviruses are commonly found are at increased risk of acquiring an arboviral infection.
COVID-19 scenario analysis
Pharmaceutical and biotechnological companies together with governments around the globe are working to combat the COVID-19 outbreak, from supporting the development of vaccines to scheduling medicines supply chain challenges. Around 115 vaccine candidates and other 155 molecules are in the R&D pipeline. Furthermore, the commonly used drugs, such as hydroxychloroquine, have observed huge boost in demand for the management of COVID-19. In addition, increase has been experienced in the demand for COVID-19 management drugs, which is expected to offer potential opportunity for manufacturers of drugs, as many developed countries are short of these drugs. Owing to the growing demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a substantial growth in the next few years.
Top impacting factors: market scenario analysis, trends, drivers, and impact analysis
The major factor affecting the arthropod born viral infections market include increase in the prevalence of several arbovirus disorders. This would help the market to gain traction over the next few years. Furthermore, increase in healthcare expenditure is anticipated to boost the market in the coming years. However, lack of awareness regarding the infectious diseases may hinder the growth of the arthropod born viral infections market over the forecast period.
Rise in incidence of encephalitis
The steep increase in the number of incidences of encephalitis would help the arthropod born viral infections market to flourish in the forecast period. According to the estimates given by the World Health Organization in 2019, Japanese encephalitis virus (JEV) is one of the major causes of viral encephalitis in various countries of Asia, and is estimated to cause 68,000 clinical cases every year. Furthermore, the fatality rate among those with encephalitis can be observed to be as high as 30%. In addition to this, there can be other side effects of the JEV, which include permanent neurologic or psychiatric sequelae. This may occur in about 30–50% of the patient population. Thus, growth in the patient population of encephalitis may propel the growth of the market in the coming years.
Surge in number of product launches for diagnostics of the disease
Increase in the number of molecular diagnostic techniques to identify the infection is anticipated to help the arthropod born viral infections market boost in the coming years. For instance, in October 2019, Co-Diagnostics, Inc. announced that the diagnostic method for the identification of the encephalitis virus will be ready in 2020. This is a Biotech company having a patented platform for the development of the molecular diagnostic tests. The test for eastern equine encephalitis (EEE) is stated to get ready in the next mosquito season, which is during 2020. Increase in R&D to develop diagnostic methods for the identification of potential encephalitis virus is expected to gain the attention of the majority of the civil population, and hence the awareness toward the encephalitis virus tends to increase. This is expected to help the market to gain traction in the next few years.
Key benefits of the report:
- This study presents the analytical depiction of the global arthropod born viral infections industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global arthropod born viral infections market share.
- The current market is quantitatively analyzed to highlight the global arthropod born viral infections market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the arthropod born viral infections market .
- The report provides a detailed global arthropod-born viral infections market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the arthropod born viral infections market research report:
- Which are the leading players active in the arthropod born viral infections market?
- What are the current trends that will influence the arthropod born viral infections market in the next few years?
- What are the driving factors, restraints, and opportunities of the arthropod born viral infections market ?
- What are the projections for the future that would help in tasking further strategic steps?
Arthropod Born Viral Infections Market, by Test Type Report Highlights
| Aspects | Details |
 By Test Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Diste., AESKU.GROUP,, Agilent Technologies,, BioMed,, Fluke Biomedical,, Datrend System,, Acmas Technologie,, Ahlborn,, Copley Scientific,, Bio-Rad, |
Loading Table Of Content...
